Depression and heart health (Credit: Canva)
Heart disease is often linked to high cholesterol, obesity, or lack of exercise. However, there is mounting evidence that suggests that mental health plays a crucial role in cardiovascular well-being. Stress, anxiety, and depression can silently strain the heart, increasing the risk of serious complications.
A recent study, published in Nature Human Behaviour, showed that loneliness has a significant impact on proteins present in a person's blood. For the study, researchers used data from more than 42,000 participants to explore whether the 9.3% who reported social isolation and 6.4% who reported loneliness had different levels of proteins in their blood compared with those who did not. The researchers then studied data that tracked the health of participants over an average 14-year period.
"We found around 90% of these proteins are linked to the risk of mortality," Dr Chun Shen, Fudan University in China, who is also the lead researcher said. "In addition, about 50% of the proteins were linked to cardiovascular disease, type 2 diabetes and stroke," he added.
Dr Shrey Kumar Srivastav, senior consultant at Sharda Hospital, said that subtle symptoms of heart disease, such as fatigue, shortness of breath, swelling in the lower legs, dizziness, and jaw pain, are often overlooked or attributed to stress and ageing. "Women, in particular, may experience atypical signs like extreme fatigue, indigestion, or upper abdominal pain instead of classic chest pain, leading to delayed diagnosis," he added.
Can Mental Health Issues Trigger Heart Diseases?
Chronic stress can trigger harmful cardiovascular effects, including elevated blood pressure, increased heart rate, and inflammation—key contributors to heart disease. Anxiety and depression further impact heart health by disrupting sleep patterns, raising stress hormone levels, and encouraging unhealthy habits like poor diet and inactivity.
Mental health issues like depression and anxiety have a profound impact on the heart. They don’t just affect emotions but can increase inflammation and put extra strain on the cardiovascular system, warns Dr Srivastav.
Certain risk factors, such as obesity and diabetes, disproportionately affect women, making them more vulnerable to heart failure with preserved ejection fraction (HFpEF). However, due to gender-specific symptom variations, heart disease in women often goes undiagnosed for longer.
Obesity is more prevalent in women than men and is a major risk factor for heart failure. Diabetes, too, has a greater impact on women’s heart health, yet diagnosis and treatment delays are common. Addressing this gap requires increasing awareness, training healthcare providers, and promoting early diagnostic tools,” explains Dr Srivastav.
How Can You Protect Your Heart?
A simple yet effective way to support heart health is by committing to a brisk 30-minute walk daily. Walking not only helps regulate blood pressure and manage weight but also improves circulation and reduces stress.
"Regular physical activity, paired with a heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins, significantly lowers cardiovascular risks," advises Dr Srivastav.
Heart disease can often go undetected until a major event occurs, making routine screenings essential.
- For women: Begin screenings around age 30 and continue with regular checkups.
- For men: Start screenings at age 35.
Health screenings, including blood pressure checks, cholesterol tests, and electrocardiograms (ECGs), are critical for early detection of silent heart conditions.
Credit: iStock/Wegovy
India's drug regulator, the Central Drugs Standard Control Organization (CDSCO), has approved Wegovy (semaglutide injection 2.4 mg) for the treatment of adults with fatty liver disease, Novo Nordisk announced today.
According to the company, Wegovy is the first and only GLP-1 receptor agonist (GLP-1 RA) approved globally and in India for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis, alongside a reduced-calorie diet and increased physical activity.
"People with MASH face a higher risk of serious liver complications and heart-related disease. This approval is an important milestone, giving doctors and patients a new treatment option while also helping address obesity and related heart and metabolic diseases," said Vikrant Shrotriya, Managing Director, Novo Nordisk India.
The approval is based on findings from the ESSENCE clinical trial, which showed that:
Semaglutide injection (Wegovy) is indicated, alongside a reduced-calorie diet and increased physical activity, for:
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease caused by excess fat accumulation in the liver, leading to chronic inflammation and liver damage.
According to Novo Nordisk, two in three Indians have fatty liver disease. The condition is often called a "silent disease" because many people do not develop symptoms until liver damage has become advanced. If left untreated, MASH can progress to severe liver complications.
"MASH is becoming more common in India as lifestyles change. In many people, early MASH has no obvious symptoms, so the condition may not be diagnosed until liver damage is more advanced," said Dr. Dharmesh Kapoor, Senior Consultant Hepatologist, Hyderabad.
He stressed the importance of early screening, particularly for people with obesity, type 2 diabetes, or other metabolic conditions.
"Wegovy has demonstrated benefits in reducing liver inflammation and fibrosis while also supporting weight management and blood sugar control, both of which are linked to MASH progression," Dr. Kapoor added.
Novo Nordisk said innovator semaglutide is backed by more than 50 clinical trials, 49 million patient-years of exposure, and extensive real-world evidence.
The medicine, manufactured using recombinant DNA (rDNA) technology, has been approved in 75 countries, including by the Drugs Controller General of India (DCGI), the European Medicines Agency (EMA), the US Food and Drug Administration (FDA), and Japan's Pharmaceuticals and Medical Devices Agency (PMDA).
Credit: iStock
Planning an overseas holiday this summer? The UK government is urging British travellers to be aware of the dangers of methanol poisoning.
The warning comes after reports of British nationals becoming seriously ill or dying after unknowingly consuming alcohol tainted with methanol in popular tourist destinations.
The UK government has now added warnings about methanol poisoning to its travel advice for 29 destinations, including popular holiday hotspots such as Indonesia, Laos and Vietnam.
"We are working to raise awareness of the warning signs of methanol poisoning and urge anyone who suspects they may have been exposed to seek immediate medical attention, helping British nationals stay safe overseas," said Minister for Consular Hamish Falconer MP.
He urged travelers to check the latest travel advice before departure and act immediately if they suspect methanol poisoning.
Also read: Cyclospora Parasite: CDC, FDA Trace Outbreak In 5 States To Taco Bell Lettuce Supplier
As part of its 'Know the Signs' campaign, the Foreign, Commonwealth & Development Office (FCDO) has released new videos featuring the families and friends of British nationals who died after unknowingly drinking methanol-contaminated alcohol overseas.
The campaign includes first-hand testimonies from survivors and bereaved families to raise awareness of the warning signs and encourage travelers to seek urgent medical help if methanol poisoning is suspected.
"No one expects a holiday to end in tragedy, yet methanol poisoning can have devastating—and sometimes fatal—consequences. The courage of survivors and bereaved families in sharing their experiences will help raise awareness and could save lives," Falconer added.
Methanol is a highly toxic industrial alcohol that can sometimes be present in counterfeit, illegally produced or contaminated alcoholic drinks.
As little as 30 ml—about one shot—can be fatal for an adult, while even smaller amounts can cause permanent blindness, brain damage and other life-threatening complications.
One of the biggest dangers is that there is no reliable way to tell whether alcohol has been contaminated. Symptoms often do not appear until 12 to 24 hours after drinking, delaying life-saving treatment.
Read More: Botulism Cases Surge in UK: MHRA Issues Botox Safety Warning Over Rare Life-Threatening Side Effect
Early symptoms of methanol poisoning may resemble ordinary alcohol intoxication or a hangover, making it easy to miss.
Warning signs include:
Vision problems and breathlessness typically develop 12 to 48 hours after consuming contaminated alcohol.
Anyone experiencing these symptoms after drinking alcohol abroad should seek emergency medical attention immediately, as early treatment can be life-saving.
The UK government advises travellers to:
Credit: iStock
The US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have traced an ongoing Cyclospora outbreak in at least five states to shredded iceberg lettuce supplied to select Taco Bell restaurants.
The agencies have advised consumers: "Do not eat shredded iceberg lettuce from Taco Bell locations in Indiana, Kentucky, Michigan, Ohio, and West Virginia."
The FDA identified Taylor Farms as the supplier of the shredded iceberg lettuce served at the affected Taco Bell locations, where it is linked to illnesses in more than 1,644 people.
Taylor Farms is one of the world's largest producers of fresh salads and ready-to-eat foods, with production facilities across the US, Canada, Mexico, and Western Europe.
The FDA is working with the company to determine whether the contaminated lettuce was distributed to other businesses. Taco Bell has voluntarily removed the affected ingredients from the impacted restaurants.
The Cyclospora outbreak has been reported in more than 30 states. The CDC said this investigation is separate from other Cyclospora outbreaks currently being monitored nationwide.
Also read: H5N1 Bird Flu Reaches New Zealand; 12 Human Infections Reported Worldwide
Michigan has reported the highest number of cases, with state officials identifying leafy lettuce as the leading suspected source after interviewing more than 1,000 patients.
As of July 16, the state had reported more than 4,300 cases and at least 100 hospitalizations linked to the outbreak.
According to the CDC, 1,645 confirmed US cases have been reported since May 1, while more than 5,100 cases are under review to determine whether the infections were acquired domestically.
No deaths have been reported, although officials warned that confirmed case numbers could continue to increase through the end of August.
Earlier this week, Taco Bell said it has voluntarily and temporarily removed limited fresh ingredients from select restaurants as a precaution.
Notices posted at some Detroit-area Taco Bell restaurants last week informed customers that the chain was temporarily unable to serve lettuce, cilantro, onions, pico de gallo, and guacamole due to a nationwide recall, according to media reports.
The company said it will continue to monitor the situation and follow guidance from public health authorities.
"The health and safety of our guests is our top priority," Taco Bell said in a statement.
Health officials recommend:
Experts also recommend choosing whole heads of lettuce instead of bagged greens. Remove the outer leaves, wash the inner leaves thoroughly under running water, and cook produce whenever possible, as heat is the most effective way to kill Cyclospora.
Cyclospora cayetanensis is a microscopic parasite that causes cyclosporiasis, a foodborne intestinal illness. People become infected after consuming contaminated food or water.
Symptoms usually begin about one week after exposure, although they can appear anywhere from two days to more than two weeks later. Common symptoms include:
The CDC also advises people with persistent diarrheal illness to specifically request testing for Cyclospora, as routine stool tests do not always screen for the parasite.
© 2024 Bennett, Coleman & Company Limited